This article only represents the author's own views.
A fight between skincare brands owned by two of China’s wealthiest women has mesmerized the country with saturation media coverage – and left one of the pair’s formerly highflying stocks badly bruised.
In nearly a month since the skirmish began on May 17, shares of Giant Biogene Holding Co. Ltd. (2367.HK) have shed nearly 30% of their value, while Bloomage BioTechnology Corp. Ltd. (688363.SH), which initiated the dust-up, is up about 7%.
您已阅读8%（492字），剩余92%（5675字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。